Prostamax
ExperimentalKhavinson prostate bioregulator / researchExperimental
Short peptide sold as a prostate bioregulator. Not FDA-approved; not a BPH drug.
For research use only.
Key Facts
- CAS
- —
- Molecular Weight (MW)
- —
- Half-life
- —
- Unit
- mg
- Administration Route
- Subcutaneous
- Frequency
- —
- Last updated
- Aug 23, 2026
- Targets
- Prostate epithelium (proposed)
Vendor price snapshot
Price per mg is list price divided by vial size in milligrams when both are known from public vendor listings. Peptide Library does not sell peptides. Confirm live prices on the vendor site.
- Vendors listing this peptide
- 2
- Listed offers
- 2
- Price per mg range
- $2.75–$4.00/mg
Overview
Short peptide sold as a prostate bioregulator. Not FDA-approved; not a BPH drug.
Protocol
- Dosage Range
- Vendor research protocols only
- Frequency
- —
- Cycle
- —
- Administration Route
- Subcutaneous
- Reconstitution Guide
- —
- Injection Sites
- AbdomenThigh
- Timing Notes
- Educational catalog only — not medical advice
Science
Mechanism of Action
Claimed prostate-epithelium gene effects in Khavinson-series papers.
Origin
Synthetic short peptide.
Targets
Prostate epithelium (proposed)
Studies
Benefits
Historical prostate-bioregulator category
Potential Side Effects
Side Effects
- Not characterized
References
- PMID 15587334External reference